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Accepted 3 September 2013Mucolipidosis type II (ML II; MIM: 252500) is an extremely rare
lysosomal storage disease caused by homozygous or compound
heterozygous mutation in the GNPTAB gene over chromosome
12q23.2. Only eight patients have been diagnosed with this disease
in Taiwan. It is also called I-cell disease because inclusion bodies
can be found in cultures of ﬁbroblasts from these patients. A defect
in the enzyme N-acetylglucosaminyl-1-phosphotransferase leads
to progressive generalized accumulation of mucopolysaccharides
and lipids. In addition to physical disability, symptom-related
psychosocial problems at different developmental milestones
should be addressed.
The only case found in eastern Taiwan was in a 7-year, 11-
month-old boy, who presented with progressive limitation of
movement in the small joints since the age of 3 years. The boy had a
short stature [body height: 107.7 cm (3.7 SD), body weight:
19.5 kg (10e25%)], coarse facial features, puffy eyelids, a ﬂat nasal
bridge, gingival hypertrophy, malocclusion, a protruding abdomen,
claw hands, and limited range of motion of multiple joints, but no
umbilical hernia; his liver and spleen could not be palpated (Fig. 1).
A panel of enzyme assays revealed marked increases in most
lysosomal enzymes such as beta-glucuronidase of 1333.33 nmol
substrate/h/mL (normal range: 5.6e101.5 nmol substrate/h/mL)Conﬂicts of interest: none.
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range: 228e1123 nmol substrate/h/mL). Gene testing revealed
compound heterozygous mutations of 1090 C/T (R364X) and
1209 T/C (I403I) over the GNPTAB gene.
The patient’s hearing was normal. Eye examination revealed
mild bilateral corneal clouding and mild myopia (visual acuity:
0.6). Very mild mitral valve regurgitation and mild scoliosis, and
grade 1 anterior spondylolisthesis of the lumbar spine were
noted on cardiac sonography and radiography, respectively.
After entering elementary school, the patient presented
multiple somatic complaints including chest pain, difﬁculty
breathing, and bad dreams. He also had many psychosocial dif-
ﬁculties such as poor frustration tolerance, a short attention
span, quick loss of temper, and difﬁculty with impulse control;
was easily distracted during learning; and presented with
compensatory behaviors when he perceived himself to be infe-
rior to his peers. The school nurse and teachers described the
patient as “a small man with high ambition” characterized by
much activity, showing off, dangerous behaviors, and physical
accidents in school. Along with self-blame, the parents were
overindulging, and did not seem to have a plan to cope with
these difﬁculties.
To deal with these problems, the patient had regular visits to a
child psychologist to build self-esteem, improve his impulsive
behavior and negative mood, and intervention with social adapta-
tion skill training. The patient had restricted ﬁne motor skills and a
low average range of intelligence on the Wechsler Preschool and
Primary Scale of Intelligence-Revised (full IQ 82, performance IQ 85,Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Patient with mucolipidosis type II. (A) Coarse facial features, depressed nasal bridge, puffy eyelids, widely spaced teeth, thick skin, and claw hands. (B) Multiple subcutaneous
nodules around the right ankle joint. (C) Limited range of shoulder motion. Note. Published with permission from the patient and his parents.
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Fig. 2. Supporting system for families and children with genetic/rare diseases.
C.-C. Wen et al. / Tzu Chi Medical Journal 26 (2014) 52e53 53and verbal IQ 82). His relative strengths (vocabulary, comprehen-
sion, object assembly, and geometric design) and weaknesses
(arithmetic and similarities) needed to be addressed. A partial in-
dividual educational programwas arranged.
Empowerment for school teachers and nurses to enhance their
knowledge and caring techniques for students with ML II was
important. Psychosocial support for the parents and remodeling of
parentingwere also suggested (Fig. 2). Symptom-relatedpsychiatricdisorders and psychosocial adjustment problems are important is-
sues for family and children affected by rare genetic diseases. A
therapeutic daily-life correlation program should be offered for
every individual patient.Further reading
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